63rd ASH Annual Meeting and Exposition

You may search for particular presentations by typing key words, an author's name, or the title in the box below. You may specify the type of search, i.e. whether you want to see pages that contain any or all of the words you specify. The Boolean search option requires one of the keywords and, or, and not, as well as parentheses.

The search filters will allow you to restrict your search by date, session type, or abstract category and are all optional. Hold down the Ctrl key while selecting to choose more than one option in each list, or hold down the Shift key to select a range.

Search:

Restrict search results to:

Browse by Day

Thursday, December 9, 2021
Friday, December 10, 2021
Saturday, December 11, 2021
Sunday, December 12, 2021
Monday, December 13, 2021
Tuesday, December 14, 2021
Wednesday, December 15, 2021
Thursday, December 16, 2021

-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
denotes an abstract that is clinically relevant

No Restriction
Plenary
101. Red Cells and Erythropoiesis, Excluding Iron
102. Iron Homeostasis and Biology
112. Thalassemia and Globin Gene Regulation
113. Hemoglobinopathies, Excluding Thalassemia: Basic and Translational
114. Hemoglobinopathies, Excluding Thalassemia: Clinical and Epidemiological
201. Granulocytes, Monocytes, and Macrophages
203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders
301. Vasculature, Endothelial Cells and Platelets: Basic and Translational
311. Disorders of Platelet Number or Function: Clinical and Epidemiological
321. Coagulation and Fibrinolysis: Basic and Translational
322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological
331. Thrombosis
332. Anticoagulation and Antithrombotic Therapies
401. Blood Transfusion
501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational
503. Clonal Hematopoiesis, Aging and Inflammation
506. Hematopoiesis and Stem Cells: Microenvironment
508. Bone Marrow Failure
602. Disordered Gene Expression and Epigenetics in Hematologic Malignancies: Basic
603. Oncogenes and Tumor Suppressors: Basic
604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms
605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms
612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological
613. Acute Myeloid Leukemias: Clinical and Epidemiological
614. Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies
615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies
616. Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies
617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis
618. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis
621. Lymphomas: Translational—Molecular and Genetic
622. Lymphomas: Translational–Non-Genetic
623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological
624. Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological
626. Aggressive Lymphomas: Prospective Therapeutic Trials
627. Aggressive Lymphomas: Clinical and Epidemiological
631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational
632. Chronic Myeloid Leukemia: Clinical and Epidemiological
634. Myeloproliferative Syndromes: Clinical and Epidemiological
636. Myelodysplastic Syndromes—Basic and Translational
637. Myelodysplastic Syndromes – Clinical and Epidemiological
641. Chronic Lymphocytic Leukemias: Basic and Translational
642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological
651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational
652. Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
653. Myeloma and Plasma Cell Dyscrasias: Clinical-Prospective Therapeutic Trials
701. Experimental Transplantation: Basic and Translational
703. Cellular Immunotherapies: Basic and Translational
704. Cellular Immunotherapies: Clinical
711. Cell Collection and Processing
721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities
722. Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
723. Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence
731. Autologous Transplantation: Clinical and Epidemiological
732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies
801. Gene Therapies
802. Chemical Biology and Experimental Therapeutics
803. Emerging Diagnostic Tools and Techniques
901. Health Services Research—Non-Malignant Conditions
902. Health Services Research—Lymphoid Malignancies
903. Health Services Research—Myeloid Malignancies
904. Outcomes Research—Non-Malignant Conditions
905. Outcomes Research—Lymphoid Malignancies
906. Outcomes Research—Myeloid Malignancies
AI, Data Science, Computer Vision and the Hematology Laboratory of the Future
ALL: New Directions for Adult Patients
AML: So Many Options, So Little Time
ASH-a-Palooza
Aberrant Transcriptional Regulation in Development and Malignancies
Approved, But Should We Use It? - Are the New Trial Designs Effective?
Blood Therapeutics in Pandemics
CLL: Extending Survival
CML: Success Breeds More Success
Cellular Memory and Innate Immune Pathways During Myeloid Cell Development and Infection
Challenges in Multiple Myeloma Treatment
Clotting and Bleeding Conundrums
Coagulation Laboratory Potpourri
Curative Therapies and Considerations for Sickle Cell Disease
Dameshek's Riddle in Practice: Is this Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, or Hypoplastic Leukemia?
Defeating Diffuse, Double-Hit and Dogged Non-Hodgkin Lymphoma
Education Program Special Interest Session: Collaborative Hematology Networks
Financial Stewardship In an Era of Hematologic Advances in Care: Whose Value? What Price?
From Structure to Function: Next Generation Iron Therapeutics
Genetic Testing for von Willebrand Disease
Hemophilia Update: Our Cup Runneth Over
Hodgkin Lymphoma: Cure and Optimal Survivorship
How Can We Ensure That Everyone Who Needs A Transplant Can Get One?
Human Pluripotent Stem Cell-Derived Hematopoiesis: From Development to Stem Cell Therapies
Immune Evasion and Immunotherapy in Myeloid Malignancies
Immune Response to Old and New Enemies
Immunology 101: What the Practicing Hematologist Needs to Know
Indolent Lymphomas
Inherited Red Cell Disorders Beyond Hemoglobinopathies
It Takes a Village: Maximizing Supportive Care and Minimizing Toxicity During Childhood Leukemia Therapy
JOINT Session - Gene Editing 2.0: Advances in Gene Editing to Treat Genetic Blood Disorders
Joint Scientific and Education Program Symposia on Barriers to Successful Clinical Trial Design & Accrual
Large Population Genomic Studies and Red Cell Disorders: A Revisionist View
Let the CHIP(s) Fall Where They May? Burdens and Benefits of Diagnosing Clonal Hematopoiesis
Lymphoid Neoplasia: Genetics of Predisposition and Precursors
MDS: Beyond a One-Size-Fits-All Approach
MPN: New Directions
Management Strategies for Sickle Cell Disease
Molecular Basis of Disease Progression in Plasma Cell Precursor Diseases
Multi-Disciplinary Hematologic Disorders: What Is the Hematologist's Role?
Neutropenia: Doing More with Less
Novel Findings in CAR-T Cell Therapies for Hematologic Malignancies
Of Lineage and Legacy: Applications of Lineage Tracing in Hematology
Perioperative Consultative Hematology: Can You Clear My Patient for Surgery?
Platelets, Megakaryocytes and the Immune Continuum
Pregnancy in Special Populations: Challenges and Solutions
Regulators of Hematopoietic Stem Cell Development and Expansion: Bench to Bedside
Ribosomes in Hematopoiesis and Disease
Scientific Symposia on COVID-19 Vaccination in Immunocompromised Patients
Scientific Workshop on Epidemiology: Risk Prediction and Assessment - Discovery, Implementation, and Disparities
Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
Scientific Workshop on Hematology and Aging
Scientific Workshop on Hematology and Pregnancy
Scientific Workshop on Interplay Between Coagulation and Malignancy
Scientific Workshop on Myeloid Development
Scientific Workshop on Streamlining Hematology Clinical Trials
Scientific Workshop on Therapies for Sickle Cell Disease: The Windy Road to Curative Options
Scientific Workshop on Translational Molecular Diagnostics in Hematology
Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies
Special Education Session on Collaborative Hematology Networks
Special Scientific Session on Race and Science
Special Symposia on the Basic Science of Hemostasis and Thrombosis
Survivorship After Allogeneic Hematopoietic Cell Transplant
The COVID Crash: Lessons Learned from a World on Pause
The Changing Landscape of Alpha and Beta-Thalassemia Diagnosis and Treatment
The Ups and Downs of Therapy for Children with Trisomy 21 and Acute Leukemia
Trainee Didactic Sessions
Unraveling the Genetics of Bleeding: From Genotype to Phenotype
Update in Graft vs Host Disease
Viral and bacterial infections - basic insights into vascular biology and coagulation
What's New in Plasma Cell Disorders?
What's New in the Transfusion Management of Sickle Cell Disease?

No Restriction
Fundamental Science
Translational Research
Clinical Research
Clinical Research - Clinical Trials
Clinical Research - Epidemiology
Clinical Research - Health Outcomes Research
Clinical Research - Health Disparities Research
Clinical Research - Patient-Reported Outcomes
Clinical Research - Real World Evidence
Clinical Research - Registries
Clinically Relevant
Diseases
Diseases - Bleeding and Clotting
Diseases - Bleeding and Clotting - Bleeding Disorders
Diseases - Bleeding and Clotting - Hemophilia
Diseases - Bleeding and Clotting - Platelet Disorders
Diseases - Bleeding and Clotting - Thromboembolism
Diseases - Bleeding and Clotting - Thrombocytopenias
Diseases - Bleeding and Clotting - Thrombotic Disorders
Diseases - Bleeding and Clotting - VWD
Diseases - Bleeding and Clotting - Autoimmune Hemolytic Anemia
Diseases - Bone Marrow Failure Syndromes
Diseases - Bone Marrow Failure Syndromes - Acquired Marrow Failure Syndromes
Diseases - Bone Marrow Failure Syndromes - Inherited Marrow Failure Syndromes
Diseases - Bone Marrow Failure Syndromes - Aplastic Anemia
Diseases - Bone Marrow Failure Syndromes - Paroxysmal Nocturnal Hemoglobinuria
Diseases - Genetic Disorders
Diseases - Hemoglobinopathies
Diseases - Hemoglobinopathies - Sickle Cell Disease
Diseases - Hemoglobinopathies - Sickle Cell Trait
Diseases - Hemoglobinopathies - Thalassemia
Diseases - Immune Disorders
Diseases - Immune Disorders - Autoimmune Disorders
Diseases - Immune Disorders - GVHD
Diseases - Immune Disorders - GVD
Diseases - Immune Disorders - Immunodeficiency
Diseases - Immune Disorders - White Blood Cell Disorders
Diseases - Infectious Diseases
Diseases - Infectious Diseases - Viral
Diseases - Infectious Diseases - Bacterial
Diseases - Infectious Diseases - Fungal
Diseases - Infectious Diseases - Other Pathogens
Diseases - Infectious Diseases - SARS-CoV-2/COVID-19
Diseases - Lymphoid Malignancies
Diseases - Lymphoid Malignancies - Lymphoid Leukemias
Diseases - Lymphoid Malignancies - Lymphoid Leukemias - ALL
Diseases - Lymphoid Malignancies - Lymphoid Leukemias - CLL
Diseases - Lymphoid Malignancies - Lymphoid Leukemias - LGL
Diseases - Lymphoid Malignancies - Lymphoid Leukemias - Lymphoid Leukemias
Diseases - Lymphoid Malignancies - Lymphomas
Diseases - Lymphoid Malignancies - Lymphomas - Hodgkin Lymphoma
Diseases - Lymphoid Malignancies - Lymphomas - Non-Hodgkin Lymphoma
Diseases - Lymphoid Malignancies - Lymphomas - B Cell Lymphoma
Diseases - Lymphoid Malignancies - Lymphomas - T Cell Lymphoma
Diseases - Lymphoid Malignancies - Lymphomas - Indolent Lymphoma
Diseases - Lymphoid Malignancies - Lymphomas - Aggressive Lymphoma
Diseases - Lymphoid Malignancies - Plasma Cell Disorders
Diseases - Myeloid Malignancies
Diseases - Myeloid Malignancies - Acute Myeloid Malignancies
Diseases - Myeloid Malignancies - Acute Myeloid Malignancies - AML
Diseases - Myeloid Malignancies - Acute Myeloid Malignancies - APL
Diseases - Myeloid Malignancies - Chronic Myeloid Malignancies
Diseases - Myeloid Malignancies - Chronic Myeloid Malignancies - MDS
Diseases - Myeloid Malignancies - Chronic Myeloid Malignancies - MPN
Diseases - Myeloid Malignancies - Chronic Myeloid Malignancies - CML
Diseases - Myeloid Malignancies - Chronic Myeloid Malignancies - CMML
Diseases - Metabolic Disorders
Diseases - Metabolic Disorders - Iron Deficiency
Diseases - Metabolic Disorders - Iron Overload
Therapies
Therapies - Biological
Therapies - Biological - Antibody Therapy
Therapies - Biological - Bispecific Antibody Therapy
Therapies - Biological - Chimeric Antigen Receptor (CAR)-T Cell Therapies
Therapies - Biological - Checkpoint Inhibitor
Therapies - Biological - Gene Therapy
Therapies - Biological - Immunotherapy
Therapies - Biological - Infusion
Therapies - Biological - Monoclonal Antibody Therapy
Therapies - Biological - Natural Killer (NK) Cell Therapies
Therapies - Biological - Transfusion
Therapies - Biological - Transplantation
Therapies - Biological - Vaccines
Therapies - Non-Biological
Therapies - Non-Biological - Anticoagulant Drugs
Therapies - Non-Biological - Chemical Interactions
Therapies - Non-Biological - Chemotherapy
Therapies - Non-Biological - Coagulant Drugs
Therapies - Non-Biological - Devices
Therapies - Non-Biological - Opioids
Therapies - Non-Biological - Palliative Care
Therapies - Non-Biological - Pharmacology
Therapies - Non-Biological - Surgical
Therapies - Non-Biological - Radiation Therapy
Therapies - Combination Therapy
Therapies - Drug Development
Therapies - Drug-Drug Interactions
Therapies - Therapy Sequence
Adverse Events
Adverse Events - Cytokine Release Syndrome
Adverse Events - Neurotoxicity
Biological Processes
Biological Processes - Genomics
Biological Processes - Hematopoiesis
Biological Processes - Immune Mechanism
Biological Processes - Immunology
Biological Processes - Metabolism
Biological Processes - Microbiome
Biological Processes - Multi-Systemic Interactions
Biological Processes - Pathogenesis
Technology and Procedures
Technology and Procedures - Artificial Intelligence
Technology and Procedures - Bioinformatics
Technology and Procedures - Blood Banking
Technology and Procedures - Cell Expansion
Technology and Procedures - Computational Biology
Technology and Procedures - Emerging Technologies
Technology and Procedures - Gene Editing
Technology and Procedures - Genomic Profiling
Technology and Procedures - Imaging
Technology and Procedures - Machine Learning
Technology and Procedures - Molecular Testing
Technology and Procedures - Newborn Screening
Technology and Procedures - Pathology
Technology and Procedures - Radiation
Technology and Procedures - Serologic Tests
Study Population
Study Population - Adults
Study Population - Animal Models
Study Population - Elderly
Study Population - Human Embryos
Study Population - Pediatric
Study Population - Neonatal
Study Population - Pregnancy
Study Population - Young Adults
Study Population - Xenograft Models
Diversity, Equity, and Inclusion (DEI)
Diversity, Equity, and Inclusion (DEI) - Access To Care
Diversity, Equity, and Inclusion (DEI) - Age Inequities
Diversity, Equity, and Inclusion (DEI) - Anti-Racism
Diversity, Equity, and Inclusion (DEI) - Cultural Sensitivity
Diversity, Equity, and Inclusion (DEI) - Disability Inequities
Diversity, Equity, and Inclusion (DEI) - Disparities
Diversity, Equity, and Inclusion (DEI) - Equity
Diversity, Equity, and Inclusion (DEI) - Gender Inequities
Diversity, Equity, and Inclusion (DEI) - Implicit Bias
Diversity, Equity, and Inclusion (DEI) - LGBTQ Inequities
Diversity, Equity, and Inclusion (DEI) - Racial Inequities
Diversity, Equity, and Inclusion (DEI) - Racism
Diversity, Equity, and Inclusion (DEI) - Representation
Diversity, Equity, and Inclusion (DEI) - Socioeconomic Inequities
Clinical Practice (e.g. Guidelines, Health Outcomes and Services, and Survivorship, Value; etc.)
Workforce (e.g. Burnout, Career Development, Medical Education, Mentorship, Recruitment/Retention, and Systems-Based Hematology, etc.)

63rd ASH Annual Meeting and Exposition

Restrict search results to:

Meeting Program